Business Context and Reporting Period
This Form 8-K is a current report filed by Ingevity Corporation on March 1, 2017. The filing addresses Item 5.02 regarding the departure of directors or certain officers and compensatory arrangements. Specifically, the Company entered into new change in control and severance agreements with four key executive officers on the date of the report.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation structures and contractual terms.
Material Changes
The primary material change is the execution of new severance agreements that supersede previous letter agreements entered into prior to the Company's separation from WestRock Company. The new agreements establish specific financial triggers and multipliers for executive compensation in the event of termination.
Guidance, Outlook, and Management Commentary
The filing details the terms of the new agreements for the CEO, CFO, General Counsel, and Executive Vice President:
- Term: Initial three-year term with automatic annual renewal unless terminated.
- Change in Control Triggers:
- CEO: 3x multiplier of base salary and target annual incentive.
- CFO, GC, EVP: 2x multiplier of base salary and target annual incentive.
- Benefits: Full vesting of restricted stock units and performance awards (based on greater of target or actual), plus lump-sum healthcare payments.
- Termination Without Change in Control:
- CEO: 2x multiplier.
- CFO and GC: 1.5x multiplier (if terminated prior to Jan 1, 2019) or 1x thereafter.
- EVP: 1x multiplier.
- Conditions: Payouts require execution of a release of claims and adherence to 12-month non-compete and non-solicitation covenants.
Investor Verification Checklist
- Verify the specific definitions of "cause," "good reason," and "change in control" in the attached Exhibits 10.1 through 10.4.
- Confirm the current base salary and target incentive award amounts for the named executives to calculate potential severance liabilities.
- Review the status of any outstanding restricted stock units or performance awards subject to the new vesting terms.
- Assess the impact of these agreements on the Company's future compensation expense and potential cash outflows in the event of a transaction or leadership change.